| Δ9-THC | Δ9-tetrahydrocannabinol |
| 2-AG | 2-arachidonoylglycerol |
| AEA | anandamide |
| BCRP | breast cancer resistant protein |
| CB1 | cannabinoid receptor type 1 |
| CB2 | cannabinoid receptor type 2 |
| CBD | cannabidiol |
| CBN | cannabinol |
| CNS | central nervous system |
| DOHaD | developmental origins of health and disease |
| eCB | endocannabinoid |
| EPCAM | epithelial cell adhesion molecule |
| ER | endoplasmic reticulum |
| FAAH | fatty acid amide hydrolase |
| FGR | fetal growth restriction |
| GR | glucocorticoid receptor |
| Glut1 | glucose transporter 1 |
| GPCR | g protein-coupled receptor |
| GPR | orphan G protein-coupled receptor |
| HUVEC | human umbilical vein endothelial cells |
| IUGR | intrauterine growth restriction |
| MAM | mitochondrial-associated ER membrane |
| mtCB1 | mitochondrial cannabinoid receptor type 1 |
| NAFLD | non-alcoholic liver disease |
| NAPE-PLD | N-acylphosphatidylethanolamine-specific phospholipase D |
| P-gp | P-glycoprotein |
| ROS | reactive oxygen species |
| T2D | type II diabetes |
| VEGFR-1 | vascular endothelial growth factor 1 |